Fasting Plasma Glucose (FPG)
Cinnamomum zeylanicum → Fasting Plasma Glucose (FPG)
Cinnamomum zeylanicum → Fasting Plasma Glucose (FPG)
Evidence profile
Key finding
Reduction in fasting blood glucose levels in the cinnamon group was found -35.50% (95% CI, -173 to 58.4).
This study evaluated the effects of Cinnamomum zeylanicum on glycemic control in individuals with type 2 diabetes, finding significant reductions in fasting plasma glucose levels.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Cinnamomum zeylanicum, Placebo
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Primary outcome
Fasting Plasma Glucose (FPG)
Comparator
Placebo Group
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
This study evaluated the effects of Cinnamomum zeylanicum on glycemic control in individuals with type 2 diabetes, finding significant reductions in fasting plasma glucose levels.
Effective management of blood sugar levels is crucial for individuals with type 2 diabetes to prevent complications. The significant reduction in fasting plasma glucose levels observed with Cinnamomum zeylanicum indicates its potential as a complementary treatment option, which could improve patient outcomes and enhance glycemic control strategies.
The study's sample size may limit the generalizability of the findings. The duration of the intervention was not specified, which could affect long-term outcomes. Potential confounding factors were not fully addressed.
Published in
Publication details and source links for this paper.
Alexander M, John RA, Anindita M, et al. Effects of Cinnamomum zeylanicum on Glycemic Control in Type 2 Diabetes: A Randomized Controlled Trial. Cureus. 2023;15(2):e35023. doi:10.7759/cureus.35023
Save this study and add notes to your research library.
Cinnamomum zeylanicum reduced fasting plasma glucose by 35.5% (p=0.001).
Glycosylated hemoglobin (HbA1c) decreased by 0.85% in the cinnamon group (p=0.039).
Significant inhibition of PTP1B expression was observed (p=0.039).
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Cinnamomum zeylanicum and Fasting Plasma Glucose (FPG), HbA1c, PTP1B expression.
This study contributes evidence to
Primary intervention
Cinnamomum zeylanicum
Primary outcomes
Evidence topics
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
2
Related topics
3
Evidence pairs
270
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
Cinnamomum zeylanicum → Fasting Plasma Glucose (FPG)
Cinnamomum zeylanicum → Fasting Plasma Glucose (FPG)
Evidence profile
Cinnamomum zeylanicum → HbA1c
Cinnamomum zeylanicum → HbA1c
Evidence profile
Cinnamomum zeylanicum → PTP1B expression
Cinnamomum zeylanicum → PTP1B expression
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Cinnamomum zeylanicum and Fasting Glucose, Cinnamomum zeylanicum and HbA1c.
This study contributes to the evidence on the following intervention-outcome relationships.
Curated evidence collections and hubs this study is part of.
All studies on Cinnamomum zeylanicum
Contributes to Cinnamomum zeylanicum evidence base.
All studies measuring Fasting Glucose
Measures Fasting Glucose as a key outcome.
All studies measuring HbA1c
Measures HbA1c as a key outcome.
Jump to pre-filtered views in the evidence archive.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Cinnamomum zeylanicum appears to improve Fasting Plasma Glucose (FPG).
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Fasting Plasma Glucose (FPG)
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Cinnamomum zeylanicum appears to improve HbA1c.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Cinnamomum zeylanicum appears to improve PTP1B expression.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
PTP1B expression
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Follow the topics this study contributes to.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.